196 related articles for article (PubMed ID: 7878854)
21. [Relationship between hepatitis B virus markers and quantitative HBV DNA in serum].
Huang ZX; Chen DY; Zhang QB
Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):43. PubMed ID: 14761284
[No Abstract] [Full Text] [Related]
22. Long-term passive immunoprophylaxis of B virus recurrence after liver transplantation in HBs antigen-positive patients.
Gugenheim J; Crafa F; Fabiani P; Goubaux B; Ouzan D; Mouiel J
Transplant Proc; 1993 Feb; 25(1 Pt 2):1349-50. PubMed ID: 8442140
[No Abstract] [Full Text] [Related]
23. Persistence of occult hepatitis B after removal of the hepatitis B virus-infected liver.
Ciesek S; Helfritz FA; Lehmann U; Becker T; Strassburg CP; Neipp M; Ciner A; Fytili P; Tillmann HL; Manns MP; Wedemeyer H
J Infect Dis; 2008 Feb; 197(3):355-60. PubMed ID: 18248299
[TBL] [Abstract][Full Text] [Related]
24. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
[TBL] [Abstract][Full Text] [Related]
25. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease.
Marcellin P; Samuel D; Areias J; Loriot MA; Arulnaden JL; Gigou M; David MF; Bismuth A; Reynes M; Bréchot C
Hepatology; 1994 Jan; 19(1):6-12. PubMed ID: 8276368
[TBL] [Abstract][Full Text] [Related]
26. Prophylaxis of hepatitis B virus recurrence after liver transplantation.
Testino G; Borro P; Sumberaz A
J Gastrointestin Liver Dis; 2009 Jun; 18(2):139-41. PubMed ID: 19565040
[No Abstract] [Full Text] [Related]
27. Prevention of de novo hepatitis B virus infections: more seems no better.
Mutimer D
Liver Transpl; 2010 Mar; 16(3):256-8. PubMed ID: 20209586
[No Abstract] [Full Text] [Related]
28. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection.
Matos CA; Perez RM; Lemos LB; Medina-Pestana JO; Lanzoni VP; Alberto FL; Moreira ES; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):653-7. PubMed ID: 17625434
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
[TBL] [Abstract][Full Text] [Related]
31. [Challenges regarding the treatment of viral hepatitis B].
Zhang DF
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):481-2. PubMed ID: 16042876
[No Abstract] [Full Text] [Related]
32. Sequence variation of hepatitis B virus precore-core open reading frame isolated from serum and liver of children with chronic hepatitis B before and after interferon treatment.
Cabrerizo M; Bartolomé J; Otero M; Ruiz-Moreno M; Carreño V
J Med Virol; 1999 Jul; 58(3):208-14. PubMed ID: 10447414
[TBL] [Abstract][Full Text] [Related]
33. HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B.
Xie Y; Zhao H; Dai WS; Xu DZ
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):418-22. PubMed ID: 14599951
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic tests: Serological markers of hepatitis B virus].
Daikoku M
Nihon Rinsho; 2005 Jul; 63 Suppl 7():404-7. PubMed ID: 16111286
[No Abstract] [Full Text] [Related]
35. Liver transplantation for chronic hepatitis B in Asian males.
Jacobs JM; Martin P; Munoz SJ; Westerberg S; Hann HW; Moritz MJ; Rubin R; Yang S; Radomski J; Jarrell BE
Transplant Proc; 1993 Apr; 25(2):1904-6. PubMed ID: 8470221
[No Abstract] [Full Text] [Related]
36. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
Iloeje UH; Yang HI; Su J; Jen CL; You SL; Chen CJ;
Gastroenterology; 2006 Mar; 130(3):678-86. PubMed ID: 16530509
[TBL] [Abstract][Full Text] [Related]
37. Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B.
Van Thiel DH; Friedlander L; Kania RJ; Molloy PJ; Hassanein T; Wahlstrom E; Faruki H
Hepatogastroenterology; 1997; 44(15):808-12. PubMed ID: 9222695
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus replication patterns after orthotopic liver transplantation: de novo versus recurrent infection.
Douglas DD; Rakela J; Taswell HF; Krom RA; Wiesner RH
Transplant Proc; 1993 Apr; 25(2):1755-7. PubMed ID: 8470154
[No Abstract] [Full Text] [Related]
39. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
Benhamou Y; Fleury H; Trimoulet P; Pellegrin I; Urbinelli R; Katlama C; Rozenbaum W; Le Teuff G; Trylesinski A; Piketty C;
Hepatology; 2006 Mar; 43(3):548-55. PubMed ID: 16496322
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease.
Kumar M; Sharma BC; Sarin SK
J Gastroenterol Hepatol; 2008 Jun; 23(6):883-7. PubMed ID: 18070014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
